Tissue engineers have tried a number of schemes for building replacement organs out of patients’ own cells, but biophysi-cist Gabor Forgacs at the University of Missouri-Columbia has a new twist: let the cells assemble themselves. Forgacs and his team start with a printing device built by Sciperio, an R&D firm in Stillwater, OK, loaded with what he calls “bioink.” The bioink consists of spherical aggregates of many thousands of cells. The printer deposits the aggregates onto successive layers of biodegradable gel; by manipulating the composition of the gel, Forgacs can coax the aggregates to grow together to form complex structures while the gel degrades. Forgacs has already built three-dimensional blood-vessel-like modules and thinks a usable blood vessel will be ready in the near future. Another application Forgacs envisions is in cancer treatment. Doctors could take tumor cells from a patient, build an artificial replica of the tumor outside of his or her body, and see which drugs worked best on the replica before barraging the patient with different treatments.
Forget dating apps: Here’s how the net’s newest matchmakers help you find love
Fed up with apps, people looking for romance are finding inspiration on Twitter, TikTok—and even email newsletters.
How AI is reinventing what computers are
Three key ways artificial intelligence is changing what it means to compute.
These weird virtual creatures evolve their bodies to solve problems
They show how intelligence and body plans are closely linked—and could unlock AI for robots.
We reviewed three at-home covid tests. The results were mixed.
Over-the-counter coronavirus tests are finally available in the US. Some are more accurate and easier to use than others.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.